Annexin 8 and differentiation of the retinal pigment epithelium
膜联蛋白 8 与视网膜色素上皮的分化
基本信息
- 批准号:BB/I019707/1
- 负责人:
- 金额:$ 55.58万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2012
- 资助国家:英国
- 起止时间:2012 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
There are two broad aims to this research. One is to learn more about the function of a protein named annexin A8, and the other is to find out how this protein influences vision. Annexin A8 is only expressed in a few cell types, and is most abundant in the cells that line the airways of the lungs. These are termed epithelial cells, and annexin A8 is also expressed in epithelial cells in other parts of the body including the breast and eye. A consistent observation is that annexin A8 is present at high levels in epithelial cells that are mature and functioning normally. The maturation process for epithelial cells requires their development from dividing immature cells into a sheet of tightly connected non-dividing cells. As this maturation process occurs, annexin A8 levels steadily increase. Interestingly, annexin A8 levels are much lower in cancerous epithelial cells, most notably in breast cancer, and the disappearance of annexin A8 from these cells seems to be associated with a reversal of the maturation process. These observations led us to the hypothesis that annexin A8 is somehow required for epithelial cell maturation and for maintenance of the normal characteristics of the mature epithelial sheet. Support for our hypothesis came unexpectedly from a study in which we were investigating the growth and maturation of epithelial cells from the eye. In the retina, which is the part of the eye that captures light and enables us to see, there is a layer of vitally important epithelial cells that is essential for retinal health. Without these cells the neighbouring light-sensitive photoreceptors rapidly die (which is what happens in age-related macular disease). We examined the expression of all known genes when the cells underwent a drug-induced reverse-maturation process, and we found that annexin A8 levels were massively reduced when this occurred. We also found that by forcing the cells to express annexin A8, we could prevent the reverse-maturation. Here, we plan to use these epithelial cells from the eye to investigate the function of annexin A8, to find out how it maintains the mature epithelial state, and why it needs to be switched off or suppressed for maturation to reverse. Some of this work we can do using cultured cells, but we now also have the necessary strains of mice to investigate this process in vivo. We have developed a way of deleting a gene in the retinal epithelial cells, and will use this approach to delete annexin A8 in the living eye. We can then investigate the consequences of this on vision, and also examine whether or not the annexin A8-depleted epithelial cells undergo maturation reversal in the living eye. If they do, and thus behave in a manner similar to their behaviour in culture, then they may convert from epithelial cells to neurones. This would constitute a remarkable developmental feat, and in the future may pave the way for new treatments for forms of blindness caused by the loss of photoreceptors.
这项研究有两个主要目的。一个是更多地了解一种名为膜联蛋白A8的蛋白质的功能,另一个是找出这种蛋白质如何影响视力。膜联蛋白A8仅在少数细胞类型中表达,在肺气道细胞中含量最多。这些被称为上皮细胞,膜联蛋白A8也在身体其他部位的上皮细胞中表达,包括乳房和眼睛。一致的观察结果是,膜联蛋白A8在成熟和功能正常的上皮细胞中存在高水平。上皮细胞的成熟过程要求它们从未成熟细胞分裂成紧密连接的非分裂细胞。随着这一成熟过程的发生,膜联蛋白A8水平稳步上升。有趣的是,膜联蛋白A8水平在癌上皮细胞中要低得多,尤其是在乳腺癌中,这些细胞中膜联蛋白A8的消失似乎与成熟过程的逆转有关。这些观察结果使我们提出一个假设,即膜联蛋白A8在某种程度上是上皮细胞成熟和维持成熟上皮片正常特征所必需的。我们的假设出乎意料地得到了一项研究的支持,在这项研究中,我们正在研究眼睛上皮细胞的生长和成熟。视网膜是眼睛捕捉光线并使我们能够看到东西的部分,在视网膜上有一层至关重要的上皮细胞,对视网膜的健康至关重要。没有这些细胞,邻近的光敏感光细胞就会迅速死亡(这就是与年龄有关的黄斑疾病所发生的情况)。当细胞经历药物诱导的反向成熟过程时,我们检测了所有已知基因的表达,发现膜联蛋白A8水平在此过程中大量降低。我们还发现,通过强迫细胞表达膜联蛋白A8,我们可以阻止细胞的反向成熟。在这里,我们计划利用这些来自眼睛的上皮细胞来研究膜联蛋白A8的功能,找出它是如何维持成熟上皮状态的,以及为什么它需要被关闭或抑制才能逆转成熟。其中一些工作我们可以用培养的细胞来完成,但我们现在也有必要的小鼠品系来研究体内的这个过程。我们已经开发了一种删除视网膜上皮细胞中的基因的方法,并将使用这种方法删除活体眼睛中的膜联蛋白A8。然后,我们可以研究这对视力的影响,并检查膜联蛋白a8耗尽的上皮细胞是否在活体眼睛中经历成熟逆转。如果它们这样做,并因此表现出与培养中的行为相似的方式,那么它们可能会从上皮细胞转化为神经元。这将构成一项了不起的发育壮举,并可能在未来为治疗由光感受器丧失引起的各种失明铺平道路。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Retinal Pigment Epithelial Cells Mitigate the Effects of Complement Attack by Endocytosis of C5b-9.
- DOI:10.4049/jimmunol.1500937
- 发表时间:2015-10-01
- 期刊:
- 影响因子:0
- 作者:Georgiannakis A;Burgoyne T;Lueck K;Futter C;Greenwood J;Moss SE
- 通讯作者:Moss SE
Regulation of retinal pigment epithelial cell phenotype by Annexin A8.
- DOI:10.1038/s41598-017-03493-3
- 发表时间:2017-07-05
- 期刊:
- 影响因子:4.6
- 作者:Lueck K;Carr AF;Stampoulis D;Gerke V;Rescher U;Greenwood J;Moss SE
- 通讯作者:Moss SE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen Moss其他文献
Student Perspectives on Pharmacy Curriculum and Instruction in Egyptian Schools
- DOI:
10.1016/s0002-9459(24)07620-4 - 发表时间:
2006-01-01 - 期刊:
- 影响因子:
- 作者:
El-Sayed E. El-Awady;Stephen Moss;David Mottram;James O'Donnell - 通讯作者:
James O'Donnell
Herbicides and their mechanisms of action. Sheffield Biological Sciences, Volume 6. Edited by Andrew Cobb and Ralph Kirkwood. 2000.
- DOI:
10.1023/a:1011288118017 - 发表时间:
2001-01-01 - 期刊:
- 影响因子:1.900
- 作者:
Stephen Moss - 通讯作者:
Stephen Moss
Adaptation of grassweeds to spring cropping through changes in germination, flowering time and fecundity
通过发芽、开花时间和繁殖力的变化使杂草适应春季种植
- DOI:
10.1038/s41598-025-04664-3 - 发表时间:
2025-07-01 - 期刊:
- 影响因子:3.900
- 作者:
Jasper Kanomanyanga;John Cussans;Stephen Moss;Erick Ober;Chun Liu;Shaun Coutts - 通讯作者:
Shaun Coutts
Stephen Moss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen Moss', 18)}}的其他基金
A Phase I/IIa Clinical Trial of a Humanised Monoclonal Antibody Against LRG1
LRG1人源化单克隆抗体I/IIa期临床试验
- 批准号:
MR/N006410/1 - 财政年份:2016
- 资助金额:
$ 55.58万 - 项目类别:
Research Grant
Lipofuscin and the complement system in retinal pigment epithelial cell biology
视网膜色素上皮细胞生物学中的脂褐素和补体系统
- 批准号:
MR/M02282X/1 - 财政年份:2015
- 资助金额:
$ 55.58万 - 项目类别:
Research Grant
Development of a therapeutic antibody for a novel angiogenic target
开发针对新型血管生成靶点的治疗性抗体
- 批准号:
G0902206/1 - 财政年份:2011
- 资助金额:
$ 55.58万 - 项目类别:
Research Grant
Modulation of phospholipid metabolism by annexins
膜联蛋白对磷脂代谢的调节
- 批准号:
BB/D018099/1 - 财政年份:2006
- 资助金额:
$ 55.58万 - 项目类别:
Research Grant
相似国自然基金
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
- 批准号:82370979
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
- 批准号:82370801
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
- 批准号:82371517
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
- 批准号:82371711
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
- 批准号:82370906
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
- 批准号:82370988
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
- 批准号:82370780
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
TNFAIP8/Hippo/SIX1轴调控软骨干细胞分化能力在颞下颌骨关节炎中的机制研究
- 批准号:82370980
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
转录因子CEBPE调控不同亚型AML细胞分化机制及靶向治疗研究
- 批准号:32000497
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
中性粒细胞在体内条件下重编程为造血干祖细胞的研究
- 批准号:92068101
- 批准年份:2020
- 资助金额:80.0 万元
- 项目类别:重大研究计划
相似海外基金
The role of non-coding variants in Usher disease
非编码变异在亚瑟病中的作用
- 批准号:
10588508 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Rod photoreceptor regeneration in a zebrafish model of Retinitis Pigmentosa.
色素性视网膜炎斑马鱼模型中杆状光感受器的再生。
- 批准号:
10607557 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Partial epigenetic reprogramming of retinal pigment cells in age-related degeneration, dysfunction, and injury
视网膜色素细胞在年龄相关变性、功能障碍和损伤中的部分表观遗传重编程
- 批准号:
10644270 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Correction of diabetic retinopathy by mitochondrial transfer
通过线粒体转移纠正糖尿病视网膜病变
- 批准号:
10658455 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
The role of the TET-dependent DNA demethylation pathway in photoreceptor development and pathology
TET依赖性DNA去甲基化途径在光感受器发育和病理学中的作用
- 批准号:
10709133 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
AAV-mediated Müller glia reprogramming to early-stage retinal progenitor cells
AAV介导的穆勒胶质细胞重编程为早期视网膜祖细胞
- 批准号:
10605472 - 财政年份:2023
- 资助金额:
$ 55.58万 - 项目类别:
Expanding retinal regenerative potential through chromatin biology in single cells
通过单细胞染色质生物学扩大视网膜再生潜力
- 批准号:
10463028 - 财政年份:2022
- 资助金额:
$ 55.58万 - 项目类别:
Neurogenic potential of murine Müller glia following retinal injury and conditional inactivation of p27Kip1
视网膜损伤和 p27Kip1 条件失活后小鼠 Müller 胶质细胞的神经源性潜力
- 批准号:
10354817 - 财政年份:2022
- 资助金额:
$ 55.58万 - 项目类别: